Abilify and Zomig drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Abilify (aripiprazole) and Zomig (zolmitriptan). Common drug interactions include convulsion among females and chronic hepatic failure among males.
The phase IV clinical study analyzes what interactions people have when they take Abilify and Zomig. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,456 Abilify users. Check the latest studies of Abilify.
What is Zomig?
Zomig has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 7,356 Zomig users. Check the latest studies of Zomig.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
67 people who take Abilify and Zomig together, and have interactions are studied.

What are the common drug interactions of Abilify and Zomig, by gender? *:
female:
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Diabetes mellitus inadequate control
- Diabetic coma
- Diabetic complication
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Neuropathy peripheral (surface nerve damage)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Tremor (trembling or shaking movements in one or more parts of your body)
- Drug hypersensitivity
- Gastric disorder (disease of stomach)
male:
- Chronic hepatic failure (long lasting liver failure)
- Death
- Drug hypersensitivity
What are the common drug interactions of Abilify and Zomig, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Nausea (feeling of having an urge to vomit)
- Presyncope
- Tremor (trembling or shaking movements in one or more parts of your body)
- Vertigo
- Blood cholesterol increased
- Blood triglycerides increased
- Hyperlipidaemia (presence of excess lipids in the blood)
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Obesity (having too much body fat)
- Type 1 diabetes mellitus
30-39:
- Blood cholesterol increased
- Blood triglycerides increased
- Hyperlipidaemia (presence of excess lipids in the blood)
- Muscular weakness (muscle weakness)
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Nasopharyngitis (inflammation of the nasopharynx)
- Night sweats (sweating in night)
- Obesity (having too much body fat)
- Pain
- Suicidal ideation
40-49:
- Neck pain
- Oedema peripheral (superficial swelling)
- Peroneal nerve palsy
- Pseudolymphoma (group of disorders having a benign course but exhibiting clinical and histological features suggestive of malignant lymphoma)
- Sensory loss (senses loss)
- Skin exfoliation (removal of the oldest dead skin cells)
- Speech disorder
- Stress
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Temperature intolerance (inability to go in temperature)
50-59:
- Avulsion fracture (bone fracture)
- Bone disorder
- Fall
- Foot fracture
- Mitral valve prolapse (heart's mitral valve doesn't work well)
- Osteoporosis (bones weak and more likely to break)
- Tibia fracture (fracture of lower leg bone)
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Drug hypersensitivity
- Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
60+:
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Restlessness (not able to rest)
- Stress
- Abdominal pain
- Abdominal tenderness
- Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
- Back pain
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 28.36%
- Stress And Anxiety: 11 people, 16.42%
- Bipolar Disorder (mood disorder): 10 people, 14.93%
- Insomnia (sleeplessness): 9 people, 13.43%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 10.45%
- Weight Decreased: 6 people, 8.96%
- Sleep Disorder: 5 people, 7.46%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 7.46%
- Nausea (feeling of having an urge to vomit): 4 people, 5.97%
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 4 people, 5.97%
* Approximation only. Some reports may have incomplete information.
Do you take Abilify and Zomig?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Abilify and Zomig:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zomig:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abilify and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zomig and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole and zolmitriptan (the active ingredients of Abilify and Zomig, respectively), and Abilify and Zomig (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cinqair cause Muscle Aches? - 3 seconds ago
- Could Enbrel cause Increased Bronchial Secretion? - 17 seconds ago
- Could Grape cause Body Height Decreased? - 17 seconds ago
- Could Erelzi cause Spinal Osteoarthritis? - 22 seconds ago
- Could Gemzar cause Blood Alkaline Phosphatase Increased? - 29 seconds ago
- Could Remodulin cause Abnormal Behavior? - 29 seconds ago
- Omega-3 Fatty Acids vs. Fluvastatin, side effect and effectiveness comparison - 30 seconds ago
- Could Synthroid cause Vaginal Bleeding Between Periods? - 32 seconds ago
- Could Simvastatin cause Peripheral Vascular Disorder? - 33 seconds ago
- Could Zoloft cause Pulmonary Valve Stenosis? - 33 seconds ago